Recent News

• 06.12.2025 - Legend Biotech 2025 Annual General Meeting
• 06.12.2025 - Legend Biotech 2025 Annual General Meeting
• 06.03.2025 - Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI® in Multiple Myeloma at 2025 ASCO Annual Meeting
• 06.03.2025 - Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI® in Multiple Myeloma at 2025 ASCO Annual Meeting
• 06.01.2025 - 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
• 06.01.2025 - 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
• 05.22.2025 - Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT
• 05.22.2025 - Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT
• 05.19.2025 - Legend Biotech to Host Investor Event During the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
• 05.19.2025 - Legend Biotech to Host Investor Event During the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

Recent Filings

• 06.03.2025 - EX-99.1 EX-99.1
• 06.03.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 05.23.2025 - EX-99.1 EX-99.1
• 05.23.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 05.14.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]